EP3494138 - COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 30.09.2022 Database last updated on 03.09.2024 | |
Former | Examination is in progress Status updated on 15.04.2020 | ||
Former | Request for examination was made Status updated on 10.05.2019 | ||
Former | The international publication has been made Status updated on 10.02.2018 | ||
Former | unknown Status updated on 01.09.2017 | Most recent event Tooltip | 30.09.2022 | Application deemed to be withdrawn | published on 02.11.2022 [2022/44] | Applicant(s) | For all designated states TCR2 Therapeutics Inc. 100 Binney Street, 7th Floor Cambridge, Massachusetts 02142 / US | [N/P] |
Former [2019/24] | For all designated states TCR2 Therapeutics Inc. 100 Binney Street 7th Floor Cambridge, Massachusetts 02142 / US | Inventor(s) | 01 /
BAEUERLE, Patrick 450 Kendall Street Cambridge, Massachusetts 02142 / US | 02 /
SIECZKIEWICZ, Gregory 450 Kendall Street Cambridge, Massachusetts 02142 / US | 03 /
HOFMEISTER, Robert 4 Jason's Lane Scituate, Massachusetts 02066 / US | [2019/24] | Representative(s) | Kilburn & Strode LLP Lacon London 84 Theobalds Road Holborn London WC1X 8NL / GB | [N/P] |
Former [2019/24] | Cornish, Kristina Victoria Joy, et al Kilburn & Strode LLP Lacon London 84 Theobalds Road London WC1X 8NL / GB | Application number, filing date | 17754238.8 | 02.08.2017 | [2019/24] | WO2017US45159 | Priority number, date | US201662370189P | 02.08.2016 Original published format: US 201662370189 P | [2019/24] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2018026953 | Date: | 08.02.2018 | Language: | EN | [2018/06] | Type: | A1 Application with search report | No.: | EP3494138 | Date: | 12.06.2019 | Language: | EN | The application published by WIPO in one of the EPO official languages on 08.02.2018 takes the place of the publication of the European patent application. | [2019/24] | Search report(s) | International search report - published on: | EP | 08.02.2018 | Classification | IPC: | C07K16/28, C07K14/705 | [2019/24] | CPC: |
C07K14/705 (EP,US);
C07K14/7051 (EP,US);
A61K35/17 (US);
A61K39/4611 (EP);
A61K39/4631 (EP);
A61K39/4644 (EP);
A61P35/00 (EP);
A61P35/02 (EP);
A61P37/04 (EP);
A61P43/00 (EP);
C07K14/70521 (US);
C07K16/2878 (EP,US);
A61K2035/124 (US);
A61K2039/505 (EP,US);
A61K2039/5156 (US);
A61K2239/31 (EP);
A61K2239/38 (EP);
C07K2317/24 (US);
C07K2317/569 (US);
C07K2317/622 (EP,US);
C07K2317/73 (EP,US);
C07K2319/02 (US);
C07K2319/03 (EP,US);
C07K2319/33 (EP,US);
C07K2319/74 (EP,US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/24] | Title | German: | ZUSAMMENSETZUNGEN UND VERFAHREN FÜR TCR-PROGRAMMIERUNG MIT FUSIONSPROTEINEN | [2019/24] | English: | COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS | [2019/24] | French: | COMPOSITIONS ET MÉTHODES DE REPROGRAMMATION DE TCR EN UTILISANT DES PROTÉINES DE FUSION | [2019/24] | Entry into regional phase | 08.02.2019 | National basic fee paid | 08.02.2019 | Designation fee(s) paid | 08.02.2019 | Examination fee paid | Examination procedure | 08.02.2019 | Examination requested [2019/24] | 08.02.2019 | Date on which the examining division has become responsible | 23.09.2019 | Amendment by applicant (claims and/or description) | 20.04.2020 | Despatch of a communication from the examining division (Time limit: M06) | 23.10.2020 | Reply to a communication from the examining division | 24.01.2022 | Despatch of a communication from the examining division (Time limit: M04) | 04.06.2022 | Application deemed to be withdrawn, date of legal effect [2022/44] | 28.06.2022 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2022/44] | Fees paid | Renewal fee | 27.08.2019 | Renewal fee patent year 03 | 27.08.2020 | Renewal fee patent year 04 | 27.08.2021 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XI]WO2015158671 (CELLECTIS [FR]) [X] 1-32,35-51,56-64,67-110 * p. 40 li. 29-31, p. 41 li. 19-23, p. 6 li. 11-12, p. 6 li. 25-26, p. 51 li. 3-8, p. 9 li. 29-30, p. 56 li. 31, p. 53 li. 12-14, p. 47 li. 13-15, p. 45 li. 21-24, p. 6 li. 7-8, p. 24 li. 26-28, p. 25 li. 19-20, p. 17 li. 27-28, p. 25 li. 20-24, p. 7 li. 21-30, p. 23 li. 16-21, p. 9 li. 3-14, p. 80 li. 11-14, p. 45 li. 17-30, p. 51 li. 13-18, p. 71 li. 32-p. 72 li. 4, p. 74 li. 17-27, p. 45 li. 17-30, p. 44 li. 14-28 * [I] 34,52-55,65,66; | [XI]WO2016014789 (BLUEBIRD BIO INC [US]) [X] 1-32,35-51,56-64,67-110 * p. 30 li. 10-p. 31 li. 18, p. 3 li. 25-28, p. 27 li. 25-29, p. 28 li. 28-32, p. 29 li. 7-11, p. 2 li. 27, p. 13 li. 5-6, p. 16 li. 24-27, p. 3 li. 1-6, p. 21 li. 7-12, p. 19 li. 25-31, p. 24 li. 28-p. 25 li. 2, p. 4 li. 3-8, p. 29 li. 20-32, p. 30 li. 12, p. 31 li. 7, p. 25 li. 4-6, p. 25 li. 30-p. 26 li. 12, p. 7 li. 5-8, p. 49 li. 17-23, p. 40 li. 3-6, p. 52 li. 24-26, p. 45 li. 7-10, p. 33 li. 1-4, p. 2 li. 15-16, p. 6 li. 25, p. 8 li. 5-8, p. 66 li. 17-18, p. 8 li. 11-13, p. 8 li. 22-p. 9 li. 5, p. 79 li. 30-p. 80 li. 11, p. 73 li. 17-20, p. 76 li. 17-27;; claims 1-3, 10, 15, 49, 68-69, 71, 76-77 * [I] 34,52-55,65,66; | [E]WO2017173256 (KITE PHARMA INC [US]) [E] 1-110 * the whole document *; | [Y] - XIUFENG WU ET AL, "Protein design of IgG/TCR chimeras for the co-expression of Fab-like moieties within bispecific antibodies", MABS, US, (20150122), vol. 7, no. 2, doi:10.1080/19420862.2015.1007826, ISSN 1942-0862, pages 364 - 376, XP055417077 [Y] 1-110 * the whole document * DOI: http://dx.doi.org/10.1080/19420862.2015.1007826 | [Y] - JENNIFER D. STONE ET AL, "A novel T cell receptor single-chain signaling complex mediates antigen-specific T cell activity and tumor control", CANCER IMMUNOLOGY, IMMUNOTHERAPY, Berlin/Heidelberg, (20140801), vol. 63, no. 11, doi:10.1007/s00262-014-1586-z, ISSN 0340-7004, pages 1163 - 1176, XP055364633 [Y] 1-110 * the whole document * DOI: http://dx.doi.org/10.1007/s00262-014-1586-z | [Y] - ARVIND CHHABRA, "TCR-Engineered, Customized, Antitumor T Cells for Cancer Immunotherapy: Advantages and Limitations", THE SCIENTIFIC WORLD JOURNAL, (20110101), vol. 11, doi:10.1100/tsw.2011.10, pages 121 - 129, XP055416645 [Y] 1-110 * the whole document * DOI: http://dx.doi.org/10.1100/tsw.2011.10 | [Y] - CARPENTER R O ET AL, "B-cell Maturation Antigen Is a Promising Target for Adoptive T-cell Therapy of Multiple Myeloma", CLINICAL CANCER RESEARCH, THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, vol. 19, no. 8, doi:10.1158/1078-0432.CCR-12-2422, ISSN 1078-0432, (20130415), pages 2048 - 2060, (20130123), XP002727959 [Y] 1-110 * the whole document * DOI: http://dx.doi.org/10.1158/1078-0432.CCR-12-2422 | by applicant | EP0239400 | US4816567 | WO9109967 | EP0519596 | US5199942 | US5225539 | WO9317105 | EP0592106 | US5350674 | US5399346 | US5530101 | US5565332 | US5580859 | US5585089 | US5585362 | US5589466 | US5766886 | US5858358 | US5883223 | US6120766 | WO0129058 | US6326193 | US6331415 | WO0196584 | US6352694 | US6407213 | US6534055 | US6548640 | US6692964 | US6797514 | US2005042664 | US2005048617 | US6867041 | US6887466 | US2005100543 | US6905680 | US6905681 | US6905874 | US2005175606 | WO2006020258 | US7067318 | US7144575 | US7172869 | US7175843 | WO2007024715 | US7232566 | US7572631 | US7695936 | WO2012138475 | WO2013126712 | US8697359 | US9393257 | - MILONE et al., Mol. Ther., (20090000), vol. 17, no. 8, pages 1453 - 1464 | - JONES et al., Nature, (19860000), vol. 321, pages 522 - 525 | - REICHMANN et al., Nature, (19880000), vol. 332, pages 323 - 329 | - PRESTA, Curr. Op. Struct. Biol., (19920000), vol. 2, pages 593 - 596 | - BATZER et al., Nucleic Acid Res., (19910000), vol. 19, page 5081 | - OHTSUKA et al., J. Biol. Chem., (19850000), vol. 260, pages 2605 - 2608 | - ROSSOLINI et al., Mol. Cell. Probes, (19940000), vol. 8, pages 91 - 98 | - PADLAN, Molecular Immunology, (19910000), vol. 28, no. 4/5, pages 489 - 498 | - STUDNICKA et al., Protein Engineering, (19940000), vol. 7, no. 6, pages 805 - 814 | - ROGUSKA et al., PNAS, (19940000), vol. 91, pages 969 - 973 | - TAN et al., J. Immunol., (20020000), vol. 169, pages 1119 - 25 | - CALDAS et al., Protein Eng., (20000000), vol. 13, no. 5, pages 353 - 60 | - MOREA et al., Methods, (20000000), vol. 20, no. 3, pages 267 - 79 | - BACA et al., J. Biol. Chem., (19970000), vol. 272, no. 16, pages 10678 - 84 | - ROGUSKA et al., Protein Eng., (19960000), vol. 9, no. 10, pages 895 - 904 | - COUTO et al., Cancer Res., (19950000), vol. 55, no. 23, pages 5973s - 5977s | - COUTO et al., Cancer Res., (19950000), vol. 55, no. 8, pages 1717 - 22 | - SANDHU J S, Gene, vol. 150, no. 2, pages 409 - 10 | - PEDERSEN et al., J. Mol. Biol., (19940000), vol. 235, no. 3, pages 959 - 73 | - RIECHMANN et al., Nature, (19880000), vol. 332, page 323 | - RIECHMANN et al., Nature, (19880000), vol. 332, pages 323 - 327 | - VERHOEYEN et al., Science, (19880000), vol. 239, pages 1534 - 1536 | - SIMS et al., J. Immunol., (19930000), vol. 151, page 2296 | - CHOTHIA et al., J. Mol. Biol., (19870000), vol. 196, page 901 | - NICHOLSON et al., Mol. Immun., (19970000), vol. 34, no. 16-17, pages 1157 - 1165 | - CARTER et al., Proc. Natl. Acad. Sci. USA, (19920000), vol. 89, page 4285 | - PRESTA et al., J. Immunol., (19930000), vol. 151, page 2623 | - LANZAVECCHIA et al., Eur. J. Immunol., (19870000), vol. 17, page 105 | - BIRD et al., Science, (19880000), vol. 242, pages 423 - 426 | - HUSTON et al., Proc. Natl. Acad. Sci. USA, (19880000), vol. 85, pages 5879 - 5883 | - HOLLINGER et al., Proc Natl Acad. Sci. U.S.A., (19930000), vol. 90, pages 6444 - 6448 | - SMITH; WATERMAN, Adv. Appl. Math., (19700000), vol. 2, page 482c | - NEEDLEMAN; WUNSCH, J. Mol. Biol., (19700000), vol. 48, page 443 | - PEARSON; LIPMAN, Proc. Nat'l. Acad. Sci. USA, (19880000), vol. 85, page 2444 | - ALTSCHUL et al., Nuc. Acids Res., (19770000), vol. 25, pages 3389 - 3402 | - ALTSCHUL et al., J. Mol. Biol., (19900000), vol. 215, pages 403 - 410 | - SONG et al., Blood., (20120000), vol. 119, no. 3, pages 696 - 706 | - AGATA et al., Int. Immunol, (19960000), vol. 8, pages 765 - 75 | - FREEMAN et al., J Exp Med, (20000000), vol. 192, pages 1027 - 34 | - LATCHMAN et al., Nat Immunol, (20010000), vol. 2, pages 261 - 8 | - CARTER et al., Eur J Immunol, (20020000), vol. 32, pages 634 - 43 | - DONG et al., Mol Med, (20030000), vol. 81, pages 281 - 7 | - BLANK et al., Cancer Immunol. Immunother, (20050000), vol. 54, pages 307 - 314 | - KONISHI et al., Clin Cancer Res, (20040000), vol. 10, page 5094 | - SCHENBORN; MIERENDORF, Nuc Acids Res., (19850000), vol. 13, pages 6223 - 36 | - NACHEVA; BERZAL-HERRANZ, Eur. J. Biochem., (20030000), vol. 270, pages 1485 - 65 | - COUGOT et al., Trends in Biochem. Sci., (20010000), vol. 29, pages 436 - 444 | - STEPINSKI et al., RNA, (20010000), vol. 7, pages 1468 - 95 | - ELANGO et al., Biochim. Biophys. Res. Commun., (20050000), vol. 330, pages 958 - 966 | - NISHIKAWA et al., Hum Gene Ther., (20010000), vol. 12, no. 8, pages 861 - 70 | - URNOV et al., Nat. Rev. Genetics, (20100000), vol. 1, pages 636 - 646 | - SANDER; JOUNG, Nat. Biotech., (20140000), vol. 32, pages 347 - 55 | - JUNE et al., Nature Reviews Immunol., (20090000), vol. 9.10, pages 704 - 716 | - SAMBROOK et al., Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Press, (20120000), vol. 1-4 | - UI-TEI et al., FEBS Letters, (20000000), vol. 479, pages 79 - 82 | - GHOSH et al., Glycobiology, (19910000), vol. 5, pages 505 - 10 | - BERG et al., Transplant Proc., (19980000), vol. 30, no. 8, pages 3975 - 3977 | - HAANEN et al., J. Exp. Med., (19990000), vol. 190, no. 9, page 13191328 | - GARLAND et al., J. Immunol. Meth., (19990000), vol. 227, no. 1-2, pages 53 - 63 | - MILONE et al., Molecular Therapy, (20090000), vol. 17, no. 8, pages 1453 - 1464 | - BARRETT et al., Human Gene Therapy, (20110000), vol. 22, pages 1575 - 1586 | - IZUMOTO et al., J Neurosurg, (20080000), vol. 108, pages 963 - 971 | - ROSENBERG et al., New Eng. J. of Med., (19880000), vol. 319, page 1676 | - BARRETINA et al., Nature, (20120000), vol. 483, page 603 | - MORTON et al., Nat. Procol., (20070000), vol. 2, page 247 |